Anticancer Activity of Selenium Nanoparticles In Vitro Studies

Area of Science:

• Nanomaterial sciences
• Cancer research

Background:

• Cancer is a leading cause of death globally, driving the search for novel therapies.
• Current cancer treatments have limitations, necessitating exploration of alternative approaches.
• Nanomaterial sciences offer potential new avenues for cancer treatment.

Purpose of the Study:

• To review the anticancer potential of selenium nanoparticles.
• To discuss their efficacy across various cancer cell lines.
• To explore the mechanisms underlying their anticancer effects.

Main Methods:

• In vitro testing on prostate, breast, cervical, lung, colorectal, and liver cancer cell lines.
• Analysis of molecular mechanisms including anti-metastatic, anti-proliferative, apoptotic, and necroptotic pathways.
• Review of existing literature on selenium nanoparticle efficacy and safety.

Main Results:

• Selenium nanoparticles exhibit anticancer activity in vitro across multiple cancer types.
• Mechanisms include inhibition of migration and invasion, antiproliferative effects, and induction of apoptosis and necroptosis.
• Pharmacological potential is influenced by dose, size, and composition.
• Selenium nanoparticles demonstrate low toxicity in non-cancerous cells.

Conclusions:

• Selenium nanoparticles represent a promising therapeutic strategy for various cancers.
• Their safety profile and multifaceted mechanisms of action warrant further investigation.
• Further research into dose, size, and composition optimization is crucial for clinical translation.